Secretory MPP3 reinforce myeloid differentiation trajectory and amplify myeloid cell production

Author:

Kang Yoon-A12ORCID,Paik Hyojung3ORCID,Zhang Si Yi2ORCID,Chen Jonathan J.4ORCID,Olson Oakley C.1ORCID,Mitchell Carl A.1ORCID,Collins Amelie1ORCID,Swann James W.1ORCID,Warr Matthew R.2ORCID,Fan Rong4ORCID,Passegué Emmanuelle12ORCID

Affiliation:

1. Columbia Stem Cell Initiative, Department of Genetics and Development, Columbia University 1 , New York, NY, USA

2. Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Department of Medicine, Hem/Onc Division, University of California, San Francisco 2 , San Francisco, CA, USA

3. Center for Applied Scientific Computing, Korea Institute of Science and Technology Information, and University of Science and Technology 3 , Daejeon, South Korea

4. Department of Biomedical Engineering, Yale University 4 , New Haven, CT, USA

Abstract

Hematopoietic stem cells (HSC) and downstream lineage-biased multipotent progenitors (MPP) tailor blood production and control myelopoiesis on demand. Recent lineage tracing analyses revealed MPPs to be major functional contributors to steady-state hematopoiesis. However, we still lack a precise resolution of myeloid differentiation trajectories and cellular heterogeneity in the MPP compartment. Here, we found that myeloid-biased MPP3 are functionally and molecularly heterogeneous, with a distinct subset of myeloid-primed secretory cells with high endoplasmic reticulum (ER) volume and FcγR expression. We show that FcγR+/ERhigh MPP3 are a transitional population serving as a reservoir for rapid production of granulocyte/macrophage progenitors (GMP), which directly amplify myelopoiesis through inflammation-triggered secretion of cytokines in the local bone marrow (BM) microenvironment. Our results identify a novel regulatory function for a secretory MPP3 subset that controls myeloid differentiation through lineage-priming and cytokine production and acts as a self-reinforcing amplification compartment in inflammatory stress and disease conditions.

Funder

University of California, San Francisco

Leukemia and Lymphoma Society

National Institutes of Health

Korea Health Industry Development Institute

Ministry of Science and ICT, South Korea

Korea Institute of Science and Technology Information

New York State Stem Cell Science

University of Arizona Cancer Center

Irving Medical Center, Columbia University

Publisher

Rockefeller University Press

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3